Mostrar el registro sencillo del ítem
dc.contributor.author | Bello-Chavolla, Omar Yaxmehen | |
dc.contributor.author | Antonio-Villa, Neftali Eduardo | |
dc.contributor.author | Fermin-Martinez, Carlos A. | |
dc.contributor.author | Fernandez-Chirino, Luisa | |
dc.contributor.author | Vargas-Vazquez, Arsenio | |
dc.contributor.author | Ramirez-Garcia, Daniel | |
dc.contributor.author | Basile-Alvarez, Martin Roberto | |
dc.contributor.author | Hoyos-Lazaro, Ana Elena | |
dc.contributor.author | Carrillo Larco, Rodrigo Martín | |
dc.contributor.author | Wexler, Deborah J. | |
dc.contributor.author | Manne-Goehler, Jennifer | |
dc.contributor.author | Seiglie, Jacqueline A. | |
dc.date.accessioned | 2022-11-15T23:04:37Z | |
dc.date.available | 2022-11-15T23:04:37Z | |
dc.date.issued | 2022 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/12529 | |
dc.description.abstract | OBJECTIVE: To estimate diabetes-related mortality in Mexico in 2020 compared with 2017-2019 after the onset of the coronavirus disease 2019 (COVID-19) pandemic.RESEARCH DESIGN AND METHODS: This retrospective, state-level study used national death registries of Mexican adults aged ≥20 years for the 2017-2020 period. Diabetes-related death was defined using ICD-10 codes listing diabetes as the primary cause of death, excluding certificates with COVID-19 as the primary cause of death. Spatial and negative binomial regression models were used to characterize the geographic distribution and sociodemographic and epidemiologic correlates of diabetes-related excess mortality, estimated as increases in diabetes-related mortality in 2020 compared with average 2017-2019 rates.RESULTS: We identified 148,437 diabetes-related deaths in 2020 (177 per 100,000 inhabitants) vs. an average of 101,496 deaths in 2017-2019 (125 per 100,000 inhabitants). In-hospital diabetes-related deaths decreased by 17.8% in 2020 versus 2017-2019, whereas out-of-hospital deaths increased by 89.4%. Most deaths were attributable to type 2 diabetes (130 per 100,000 inhabitants). Compared with 2018-2019 data, hyperglycemic hyperosmolar state and diabetic ketoacidosis were the two contributing causes with the highest increase in mortality (128% and 116% increase, respectively). Diabetes-related excess mortality clustered in southern Mexico and was highest in states with higher social lag, rates of COVID-19 hospitalization, and prevalence of HbA1c ≥7.5%.CONCLUSIONS: Diabetes-related deaths increased among Mexican adults by 41.6% in 2020 after the onset of the COVID-19 pandemic, occurred disproportionately outside the hospital, and were largely attributable to type 2 diabetes and hyperglycemic emergencies. Disruptions in diabetes care and strained hospital capacity may have contributed to diabetes-related excess mortality in Mexico during 2020. | en_US |
dc.language.iso | eng | |
dc.publisher | American Diabetes Association | |
dc.relation.ispartofseries | Diabetes Care | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Diabetes Mortality | en_US |
dc.subject | Mexico | en_US |
dc.subject | National Death Registries | en_US |
dc.title | Diabetes-Related Excess Mortality in Mexico: A Comparative Analysis of National Death Registries Between 2017-2019 and 2020. | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.2337/dc22-0616 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.18 | |
dc.relation.issn | 1935-5548 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |